Skip to content

Ayurvedic management of Sandhigatavata(osteoarthritis)

MULTI MODEL AYURVEDIC MANAGEMENT OF SANDHIGATAVATA WITH SPECIAL REFERENCE TO OSTEOARTHRITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/09/006163
Enrollment
20
Registered
2015-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M15-M19- Osteoarthritis

Interventions

Intervention1: Ayurvedic classical herbal formulation: Ashvagandha churna 3gm twice in a day with milk Atibalamool kwath 40ml twice in day Narayan oil local application Nirgundi leaf local application

Sponsors

J S Ayurved College and P D Patel Ayurved Hopital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with the classical signs and symptoms of Sandhigatavata (OA), viz. Shula, Shotha, Stambha, Sparsha-asahyata, Sphutana, Akunchana Prasarane vedana etc., will be taken for the study.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from Amvata,Vatarakt. 2. Patients suffering from uncontrolled diabetes (those who have HBA1c above 7.5), Psoriatic arthritis, Gouty arthritis, Rheumatoid arthritis, Systemic Lupus Erythematosus (SLE), Bone TB and other major systemic disorders will be excluded. 3. Patients of osteoarthritis already operated for joint replacement. 4. Pregnant and lactating women will be excluded. 5. Patients who have taken corticosteroid within last 6 months.

Design outcomes

Primary

MeasureTime frame
Effect of the Ayurvedic FormulationTimepoint: Effect of the Ayurvedic Formulation After 28 Days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactNimesh Gunvantbhai Kachhiapatel

J S Ayurved College and P D Patel Ayurved Hospital

guptayurveda@yahoo.com9825261305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026